<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"
	"http://www.w3.org/TR/1998/REC-html40-19980424/loose.dtd">
<html>
<head><meta http-equiv="content-type" content="text/html; charset=UTF-8">
<style type="text/css">
 table.main {}
 tr.row {}
 td.cell {}
 div.block {}
 div.paragraph {}
 .font0 { font:7pt Arial, sans-serif; }
 .font1 { font:11pt Arial, sans-serif; }
 .font2 { font:14pt Arial, sans-serif; }
 .font3 { font:17pt Arial, sans-serif; }
 .font4 { font:10pt Times New Roman, serif; }

</style>
</head>
<body>
<p><span class="font2">JPMorgan</span></p>
<p><span class="font0" style="font-weight:bold;">Asia Pacific Equity Research</span></p>
<p><span class="font0" style="font-weight:bold;">07 September 2016</span></p>
<p><span class="font0" style="font-weight:bold;">Isabella Y. Zhao, CFA</span></p>
<p><span class="font0" style="font-weight:bold;">(852) 2800-8534</span></p>
<p><a href="mailto:isabella.zhao@jpmorgan.com"><span class="font0" style="font-weight:bold;">isabella.zhao@jpmorgan.com</span></a></p><a name="caption1"></a>
<h4><a name="bookmark0"></a><span class="font3"><a name="bookmark1"></a>Company Overview</span></h4>
<p><span class="font4">Sinopharm Group, founded in 2003, is China’s largest pharmaceutical distributor with unrivaled nationwide reach. The company had market share of 18.4% in 2015 in the pharmaceutical distribution business, far exceeding the competitors CR Pharma (5.9%) and Shanghai Pharma (5.7%). Sinopharm runs its business through more than 70 subsidiaries, 13310 nationally ranked hospitals including 1,847 largest class-three hospitals with the highest rankings, 104,508 small healthcare end-customers, and 68,264 retail pharmacies outlets throughout China. Normally small healthcare end customers include primary healthcare sendees institutions and others. As the company grows, it may conduct more sales to hospitals directly.</span></p>
<p><span class="font4">The group posted revenue of RMB 227,069 million for the year 2015 witnessing a Y-O-Y growth of 13.5%, which exceeded the industry average, which slowed down to 9.0% in 2015. In 1H16, the group recorded revenue of Rmbl26million, witnessing Y-O-Y growth of 13.4%. The company operates in the following business segments: Pharmaceutical distribution, Retail pharmacy and others.</span></p>
<p><span class="font4">Sinopharm sources over 20,000 types of products from over 3,300 domestic and international suppliers. Thirty of the top 50 international suppliers and 95% of the domestic suppliers are currently supplying Sinopharm. Sinopharm is one of the only three licensed nationwide aesthetics providers in China. The Group has, through a series of acquisitions, transformed itself into a leader in not only China but global pharmaceutical industiy and it plans to continue its efforts to further consolidate.</span></p>
<p><a name="bookmark2"></a><span class="font1" style="font-weight:bold;"><a name="bookmark3"></a>Business Segments</span></p>
<p><a name="bookmark4"></a><span class="font4" style="font-weight:bold;"><a name="bookmark5"></a>Pharmaceutical Distribution</span></p>
<p><span class="font4">Pharmaceutical distribution is the group’s principal business. It provides distribution, logistics and other value added sendees to domestic and foreign manufacturers and suppliers of pharmaceutical products, medical equipment and other healthcare products. It also supplies to downstream customers including hospitals, other distributors, retail drug stores and primaiy healthcare sendees institutions.</span></p>
<p><span class="font4">In 2015, Revenue from distribution business was RMB 213,994 million, an Y-O-Y increase of 13%, and accounts for 94.13% of the groups revenue (down from 94.87% in 2014). In 1H16, revenue from this segment was RMB118,673mn, an increase of 8.1% over the same period last year.</span></p>
<p><span class="font4">The group differentiates itself with its counterparts by its strengths of geographic coverage, the breadth of its product portfolio and the comprehensive supply chain sendees provided to its customers and suppliers.</span></p>
<p><span class="font4">As of 1H16, the distribution network covers 31 provinces, municipalities and autonomous regions across China. Sinopharm has 4 logistics hubs, 39 provincial logistics centers, 177 municipal level logistics outlets and 22 retail logistics outlets, with a sum of 242 logistics outlets. It also sets up “Sinopharm Online Co. Ltd” to grab the opportunities in pharmaceutical e-commerce and the business progresses smoothly with transaction value exceeding RMB 2,200 million.</span></p>
<p><span class="font0" style="font-weight:bold;">18</span></p>
</body>
</html>